Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
Abstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast can...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13058-024-01809-6 |
_version_ | 1827309885825482752 |
---|---|
author | Julian C. McClellan James L. Li Guimin Gao Dezheng Huo |
author_facet | Julian C. McClellan James L. Li Guimin Gao Dezheng Huo |
author_sort | Julian C. McClellan |
collection | DOAJ |
description | Abstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast cancer. Additionally, these studies were based on gene expression prediction models trained primarily in breast tissue, and they did not account for alternative splicing of genes. Methods In this study, we utilized two approaches to perform multi-tissue TWASs of breast cancer by ER subtype: (1) an expression-based TWAS that combined TWAS signals for each gene across multiple tissues and (2) a splicing-based TWAS that combined TWAS signals of all excised introns for each gene across tissues. To perform this TWAS, we utilized summary statistics for ER + BC from the Breast Cancer Association Consortium (BCAC) and for ER- BC from a meta-analysis of BCAC and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Results In total, we identified 230 genes in 86 loci that were associated with ER + BC and 66 genes in 29 loci that were associated with ER- BC at a Bonferroni threshold of significance. Of these genes, 2 genes associated with ER + BC at the 1q21.1 locus were located at least 1 Mb from published GWAS hits. For several well-studied tumor suppressor genes such as TP53 and CHEK2 which have historically been thought to impact BC risk through rare, penetrant mutations, we discovered that common variants, which modulate gene expression, may additionally contribute to ER + or ER- etiology. Conclusions Our study comprehensively examined how differences in common variation contribute to molecular differences between ER + and ER- BC and introduces a novel, splicing-based framework that can be used in future TWAS studies. |
first_indexed | 2024-04-24T19:50:14Z |
format | Article |
id | doaj.art-1149dce07d1b47f78b1ae6632b5b62de |
institution | Directory Open Access Journal |
issn | 1465-542X |
language | English |
last_indexed | 2024-04-24T19:50:14Z |
publishDate | 2024-03-01 |
publisher | BMC |
record_format | Article |
series | Breast Cancer Research |
spelling | doaj.art-1149dce07d1b47f78b1ae6632b5b62de2024-03-24T12:37:58ZengBMCBreast Cancer Research1465-542X2024-03-0126111510.1186/s13058-024-01809-6Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor statusJulian C. McClellan0James L. Li1Guimin Gao2Dezheng Huo3Department of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoDepartment of Public Health Sciences, University of ChicagoAbstract Background Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS have explored the differences in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) breast cancer. Additionally, these studies were based on gene expression prediction models trained primarily in breast tissue, and they did not account for alternative splicing of genes. Methods In this study, we utilized two approaches to perform multi-tissue TWASs of breast cancer by ER subtype: (1) an expression-based TWAS that combined TWAS signals for each gene across multiple tissues and (2) a splicing-based TWAS that combined TWAS signals of all excised introns for each gene across tissues. To perform this TWAS, we utilized summary statistics for ER + BC from the Breast Cancer Association Consortium (BCAC) and for ER- BC from a meta-analysis of BCAC and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Results In total, we identified 230 genes in 86 loci that were associated with ER + BC and 66 genes in 29 loci that were associated with ER- BC at a Bonferroni threshold of significance. Of these genes, 2 genes associated with ER + BC at the 1q21.1 locus were located at least 1 Mb from published GWAS hits. For several well-studied tumor suppressor genes such as TP53 and CHEK2 which have historically been thought to impact BC risk through rare, penetrant mutations, we discovered that common variants, which modulate gene expression, may additionally contribute to ER + or ER- etiology. Conclusions Our study comprehensively examined how differences in common variation contribute to molecular differences between ER + and ER- BC and introduces a novel, splicing-based framework that can be used in future TWAS studies.https://doi.org/10.1186/s13058-024-01809-6BreastCancerTWASEstrogenReceptorSplicing |
spellingShingle | Julian C. McClellan James L. Li Guimin Gao Dezheng Huo Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status Breast Cancer Research Breast Cancer TWAS Estrogen Receptor Splicing |
title | Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status |
title_full | Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status |
title_fullStr | Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status |
title_full_unstemmed | Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status |
title_short | Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status |
title_sort | expression and splicing based multi tissue transcriptome wide association studies identified multiple genes for breast cancer by estrogen receptor status |
topic | Breast Cancer TWAS Estrogen Receptor Splicing |
url | https://doi.org/10.1186/s13058-024-01809-6 |
work_keys_str_mv | AT juliancmcclellan expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus AT jameslli expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus AT guimingao expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus AT dezhenghuo expressionandsplicingbasedmultitissuetranscriptomewideassociationstudiesidentifiedmultiplegenesforbreastcancerbyestrogenreceptorstatus |